GeneDx Launches Online Exome Testing Offering to Expand Access to Genetic Diagnosis for Children GeneDx , a leader in rare disease diagnosis and genomic data, has announced the launch of a new digital offering designed to make exome testing more…
BioVigil Surpasses 1 Billion Hand Hygiene Opportunities, Highlighting Continued Focus on Infection Prevention and Patient Safety BioVigil, a leading provider of automated hand hygiene monitoring and infection prevention technology, has announced that its platform has recorded more than 1 billion…
Innate Pharma and Sobi Partner to Advance Lacutamab into Phase 3 Development for Cutaneous T-Cell Lymphoma Innate Pharma SA and Swedish Orphan Biovitrum AB (publ), widely known as Sobi®, have entered into a strategic partnership designed to accelerate the clinical…
Cerepeut Study in Neuron Identifies Mitochondrial Mechanism Driving Tau-Related Neurodegeneration and Highlights CP-235 as Potential Therapy Cerepeut, Inc., a biotechnology company focused on developing mitochondrial therapeutics for neurodegenerative diseases, has announced the publication of new research in Neuron that identifies…
City of Hope Study Shows Education Program Can Dramatically Improve Skin Cancer Screening Among Hematopoietic Cell Transplant Survivors Experts at City of Hope®, one of the nation’s leading cancer research and treatment organizations, are highlighting the importance of skin cancer…
ZAP Surgical Expands Presence in China with New ZAP-X Radiosurgery Installation at Changchun Tumor Hospital ZAP Surgical Systems, Inc., a global innovator in non-invasive robotic brain surgery technologies, has announced the installation of its advanced ZAP-X® Gyroscopic Radiosurgery® platform at…
Niagen Bioscience Partners with Evotec to Advance NB4168 Development for Rare Genetic Disease Niagen Bioscience, Inc. (NASDAQ: NAGE), a biotechnology company recognized for its leadership in NAD+ (nicotinamide adenine dinucleotide) science and healthy aging research, has announced a strategic collaboration…
Seaport Therapeutics Reports Second Quarter 2026 Results, Highlights Positive Clinical Progress and Strengthened Financial Position Following IPO Seaport Therapeutics, Inc., a clinical-stage biotechnology company focused on developing innovative treatments for neuropsychiatric disorders, has announced its financial results for the second…
miRecule and Rio Biofarma Brasil Partner to Advance Next-Generation RNA Delivery Technologies miRecule, Inc., a biotechnology company focused on developing next-generation RNA therapeutics for rare genetic diseases, has entered into a strategic research collaboration with Rio Biofarma Brasil Ltda. (RBBL),…
Latigo Biotherapeutics Publishes Positive Phase 2 LTG-001 Acute Pain Trial Results in The New England Journal of Medicine Latigo Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing innovative non-opioid medicines for pain management, has announced the publication of positive…
Virta Health Study Suggests Nutrition-Based Metabolic Care May Significantly Reduce Risk of Chronic Kidney Disease Virta Health, a leader in reversing metabolic disease through individualized nutrition-based care, has announced the publication of a major peer-reviewed study demonstrating that chronic kidney…
Shionogi Launches XOCOVA® in the United States as the First Oral Post-Exposure COVID-19 Prevention Therapy Shionogi Inc., the U.S. subsidiary of Japan-based pharmaceutical company Shionogi & Co., Ltd., has announced the commercial availability of XOCOVA® (ensitrelvir) in the United States…